INSIGHTS ON LIQUID DOSE MANUFACTURING

• Global Regulatory Harmonization: Comparisons In Aseptic Barrier Systems

  Compare global aseptic standards from the FDA, EMA, PIC/S, and WHO. Gain insights into how advanced barrier systems harmonize international requirements to ensure sterile product integrity and safety.

• Simulating PUPSIT Or Gas Purges In Bacterial Challenge Tests

  Managing PUPSIT‑related risks is a critical part of contamination control. Learn how bacterial retention studies, wetting fluids, and downstream practices influence sterility assurance.

• The Journey Of A CDMO Choosing Pre-Sterilized Drug Containers

  Explore innovation in pharmaceutical manufacturing with advanced drug containment, delivery systems, and automation, ensuring quality, safety, and efficiency in injectable therapies for global healthcare.

   

• Protecting Your Drug Product

  With patient lives depending on every dose, even minor vulnerabilities in containment or delivery systems can have serious consequences for product integrity and patient outcomes.

• Visual Inspection Equipment To Deliver The Highest Product Integrity

  4/1/2025

  Gain insight into an advanced inspection solution for pharmaceuticals that ensures drug integrity and reduces costs with flexible technologies, from lab development to high-volume production.

• Delivering Innovative Solutions & Relied Upon Turn-Key Systems

  5/13/2026

  Explore advanced aseptic fill-finish automation, modular isolation systems, and the technical drivers behind out-of-nest processing for ready-to-use containers.

• Isolators For Pharmacy Compounding – Time For Change?

  3/14/2025

  Maintaining a contamination-free environment is crucial in drug compounding. Learn how isolator systems can improve safety, efficiency, and regulatory compliance.

• Product-Wet Integrity Testing: Risk-Based Strategies

  5/22/2026

  When standard water‑based integrity testing falls short, product‑wet approaches can offer a more representative alternative. Learn how risk‑based strategies are used to establish reliable test limits.

• Afton Scientific Capabilities Update January 2026: Fill/Finish

  1/27/2026

  Here, Michael Dunn outlines our current available capacity, including RABS operations, alongside the commissioning of a new Annex 1–compliant isolator filling line and expanded QC capabilities to ensure reliable, scalable execution.